Old CIC Events

Dissecting metastatic Bladder Cancer
Jesús M Paramio — CIEMAT and Inst Inv Biomed Univ Hosp “12 de Octubre”

Defining mechanisms of genomic evolution in cancer
Sarah McClelland, PhD — Barts Cancer Institute, Queen Mary University of London

Academic model for CAR-T development: ARI0002h for multiple myeloma and beyond
Carlos Fernández de Larrea — Hospital Clínic de Barcelona

Preclinical and clinical evaluation of belantamab mafodotin based immunotherapy combinations in multiple myeloma
Mauro Lorenzo Mohamed — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC

Tuning the ribosome in health and disease
Anders H. Lund — Biotech Research and Innovation Centre University of Copenhagen

Inherited and acquired genetic biomarkers in patients with Mast Cell Activation Syndromes and Mastocytosis
Paula Navarro — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC

Defensa de tesis doctoral: Novel immunophenotypic approaches to improve the diagnostic study of mature T- and NK-cell neoplasms
Francisco Javier Morán Plata — PD. Biología y Clínica del Cáncer.

Dissecting the function of copy number alterations in cancer
Francisco M. Barriga — VHIO, Barcelona

Markers and vulnerabilities of senescent cells in post-therapy tumors
José Alberto López — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC